Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etacalin for Pulmonary Arterial Hypertension Phase II Study
CTR20150322Phase 2Active
- Sponsor
- Beijing Enhua Pharmaceutical Research Institute
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of etacalin in pulmonary arterial hypertension (PAH), Plexogenic Pulmonary Arteriopathy, Heritable Pulmonary Arterial Hypertension (HPAH), sponsored by Beijing Enhua Pharmaceutical Research Institute. Started Jun 2015; status: active.
02
Drugs
etacalin
03
Conditions
pulmonary arterial hypertension (PAH)Plexogenic Pulmonary ArteriopathyHeritable Pulmonary Arterial Hypertension (HPAH)
Beyond the preview
Go deeper on CTR20150322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150322.